Pfizer Urged to Wait for November to Seek Vaccine Authorization
- Scientists, ethicists recommend monitoring two months after second dose
- Pfizer pledged not to cut corners on Covid-19 vaccine
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Pfizer Inc. should wait until at least late November before seeking FDA authorization of its Covid-19 vaccine to meet rigorous safety standards, more than 60 leading researchers and bioethicists said.